Sat.Nov 19, 2022 - Fri.Nov 25, 2022

article thumbnail

Sporting a $3.5M price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line

Fierce Pharma

Sporting a $3.5M price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line. zbecker. Wed, 11/23/2022 - 10:10

FDA 247
article thumbnail

The next era of Greater Boston’s biotech boom

PharmaVoice

How Boston became the biotech capital of the U.S., and is now preparing for the next era of life sciences growth

101
101
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why You Need an ADA Compliant Healthcare Website—and How to Get One

Healthcare Success

Just like your brick-and-mortar business has to be ADA compliant, your healthcare website must also be accessible to people with disabilities. The problem? The ADA doesn’t offer clear regulations for a compliant website. The bigger problem? ADA accessibility lawsuits are on the rise.

article thumbnail

How Clinical Trials Can Thrive in the Digital Era

PharmExec

The Digital Medicine Society (DiMe) CEO Jennifer Goldsack and Takeda’s Head of Digital Health Sciences, Data Sciences Institute Shoibal Datta describe the current landscape of digitized clinical trials and the decisions needed to fully utilize their potential.

article thumbnail

On a roll, Takeda's dengue vaccine shifts into FDA's fast review lane

Fierce Pharma

On a roll, Takeda's dengue vaccine shifts into FDA's fast review lane. kdunleavy. Wed, 11/23/2022 - 09:35

FDA 242
article thumbnail

How bacteria-enabled technology for wounds could also help cancer patients

PharmaVoice

Evelina Vågesjö, co-founder and CEO of the immunotherapy company Ilya Pharma, is working on a new modality to speed wound healing

Pharma 87

More Trending

article thumbnail

Tuning Into CTV - Real Time Data For Marketers

PharmExec

In episode 122, Marcella Milliet Sciorra, Chief Marketing Officer at DeepIntent, discusses Connected TV, or CTV, how it differs from over the top, and how CTV fits into the future of pharmaceutical marketing.

article thumbnail

Senator aims to cut biosimilar 'red tape' with proposal to eliminate interchangeable status

Fierce Pharma

Senator aims to cut biosimilar 'red tape' with proposal to eliminate interchangeable status. kdunleavy. Wed, 11/23/2022 - 07:18

Pharma 242
article thumbnail

In cancers with very low survival rates, Sellas aims higher

PharmaVoice

The company hopes its drugs can “take over where other available treatments fail” in multiple types of cancer

87
article thumbnail

What Matters Most: The Trends That Will Shape Pharma Marketing in 2023

Eversana Intouch

Download the White Paper. Big concepts. Big platforms. Big words. Big decisions. That’s where we all want to play. It’s easy to toss big words around, though: to be provocative, to hype, to make unsupported claims. It’s far more difficult to be precise, accurate, meaningful. To have impact.

article thumbnail

Customer Data Platforms: A Healthcare Perspective

Penrod

The post Customer Data Platforms: A Healthcare Perspective appeared first on Penrod

article thumbnail

J&J's nasal spray Spravato bests former AZ drug Seroquel XR in treatment-resistant depression trial

Fierce Pharma

J&J's nasal spray Spravato bests former AZ drug Seroquel XR in treatment-resistant depression trial. fkansteiner. Wed, 11/23/2022 - 09:26

Pharma 241
article thumbnail

Why the biopharma ‘IPO playbook’ changed in 2022

PharmaVoice

Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound

article thumbnail

Exploring the “Other” End-User – HCPs and the Challenges to Adoption of Machine Learning-based Digital Solutions

PharmExec

Webinar Date/Time: Mon, Dec 5, 2022 2:00 PM EST. us

82
article thumbnail

Zydus Lifesciences Limited-Walk-In Interviews for B.Pharm, M.Pharm/ Diploma/ ITI in Production OSD On 27th Nov’ 2022

Pharma Pathway

Zydus Lifesciences Limited-Walk-In Interviews for B.Pharm, M.Pharm/ Diploma/ ITI in Production OSD On 27th Nov’ 2022. Job Description. We are recruiting for B.Pharm, M.Pharm/ Diploma/ ITI in Production OSD for Our Formulation Manufacturing Plant at Moraiya, Ahmedabad.

article thumbnail

Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits

Fierce Pharma

Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits. fkansteiner. Wed, 11/23/2022 - 08:05

Pharma 229
article thumbnail

AI will continue to attract investment in near future in the healthcare industry

Pharmaceutical Technology

Artificial intelligence (AI) was seen as one of the top current investment priorities and was thought to continue to attract investment in the healthcare sector in the upcoming two years, according to GlobalData's latest report ‘Digital Transformation and Emerging Technology in the Healthcare Industry - 2022 Edition’.

article thumbnail

Bottom of the Funnel Conversion though EHR Marketing and its Role in an Omnichannel Strategy

PharmExec

Webinar Date/Time: Wed, Dec 7, 2022 2:00 PM EST. us

article thumbnail

Engagement Opportunities in Healthcare’s Digital Front Door

PM360

If you aren’t yet familiar with the term “digital front door,” you soon will be. Not only because we will soon define it for you, but because you will be hearing about it a lot over the next few years.

article thumbnail

Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck

Fierce Pharma

Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck. fkansteiner. Tue, 11/22/2022 - 10:07

Pharma 229
article thumbnail

Nectar Lifesciences Ltd- Walk-In Interviews for Production / QC/ QA/ Engineering/ SRP On 27th Nov’ 2022

Pharma Pathway

Nectar Lifesciences Ltd- Walk-In Interviews for Production / QC/ QA/ Engineering/ SRP On 27th Nov’ 2022. Job Description. Walk-In Interviews for Production / QC/ QA/ Engineering/ SRP On 27th Nov’ 2022 Candidates @ Nectar Lifesciences Ltd.

article thumbnail

Biotech Startup Raises $5.4M to Develop AI-Designed Protein Machines and Cell Factories

PharmaTech

Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.

80
article thumbnail

How Banks and Credit Unions Are Getting Serious About Culture Change and Employee Engagement

Integrity Solutions

With employee turnover one of the most serious internal threats credit unions and banks face today, many forward-thinking financial institutions are taking a hard look at their organizations culture and opportunities to change.

Ethics 79
article thumbnail

ASH: AbbVie, J&J's Imbruvica under serious threat as BeiGene's Brukinsa delivers head-to-head trial win

Fierce Pharma

ASH: AbbVie, J&J's Imbruvica under serious threat as BeiGene's Brukinsa delivers head-to-head trial win. Mon, 11/21/2022 - 16:29

Pharma 219
article thumbnail

Raichem Medicare Pvt. Ltd-Walk-In Interview for Production / Shift Incharge On 21st Nov’ 2022

Pharma Pathway

Raichem Medicare Pvt. Ltd-Walk-In Interview for Production / Shift Incharge On 21st Nov’ 2022. Job Description. Walk-In Interview for Production / Shift Incharge On 21st Nov’ 2022 @ Raichem Medicare Pvt. Ltd -Hyderabad. Departments: Production / Shift Incharge. Division: API.

Safety 79
article thumbnail

Toolbox to Study Ligand Binding for Enhanced Treatments

Medgadget

Researchers at Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland have developed a DNA toolbox that allows researchers to explore binding interactions between ligands and their respective receptors based on receptor density and arrangement.

article thumbnail

What Are You Thankful For? | Legacy MEDSearch 2022

Legacy MEDSearch

The holiday season always brings a time of family, friends, good food, and also reflection on the year. This year as we are in the season of giving thanks, we asked our team what everyone was thankful for this holiday season. Here is what they had to say!

article thumbnail

Pfizer's Paxlovid access brought into question as WTO set to discuss patent waiver—again

Fierce Pharma

Pfizer's Paxlovid access brought into question as WTO set to discuss patent waiver—again. Mon, 11/21/2022 - 11:21

Pharma 219
article thumbnail

Lincoln Pharmaceuticals Ltd-Walk-In Interview for Production/ Packing/ ADL/ Packing/ QA/ QC/ F&D/ Engineering On 27th Nov’ 2022

Pharma Pathway

Lincoln Pharmaceuticals Ltd-Walk-In Interview for Production/ Packing/ ADL/ Packing/ QA/ QC/ F&D/ Engineering On 27th Nov’ 2022. Job Description.

article thumbnail

Beware of a False Sense of Cybersecurity

MedCity News

Based on some independent research that my company commissioned with more than 200 companies, we came to several conclusions that are highlighted in the article. Broadly, however, it signals the false sense of (cyber)security that many companies are currently harboring.

Patients 103
article thumbnail

New View Surgical, Inc. Closes $12.1M Series B-1 Financing, Readies Limited Market Release of its VisionPort™ System For Minimally Invasive Surgery

Legacy MEDSearch

New View Surgical, Inc., an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), announced the closure of a $12.1M Series B-1 equity financing round to fund the commercialization of its VisionPort System.

article thumbnail

'Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says

Fierce Pharma

Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says. kdunleavy. Tue, 11/22/2022 - 11:13

Pharma 207
article thumbnail

Hetero Limited-Walk-In Interview for Freshers -Production/ QA/ QC/ Maintenance On 22nd Nov’ 2022

Pharma Pathway

Hetero Limited-Walk-In Interview for Freshers -Production/ QA/ QC/ Maintenance On 22nd Nov’ 2022. Job Description. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

article thumbnail

FDA approves first gene therapy for Haemophilia B

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has approved Hemgenix (etranacogene dezaparvovec), the first gene therapy for adults with Haemophilia B (congenital Factor IX deficiency) who currently use Factor IX prophylaxis therapy, or have current or historical life-threatening haemorrhage, or have repeated, serious spontaneous bleeding episodes.